Vnitr Lek 2008, 54(10):961-964

Evaluation of alternative calculation methods for determining LDL cholesterol

B. Vohnout1,2,*, A. Vachulová1, P. Blažíček3, A. Dukát1, G. Fodor4, J. Lietava1
1 2nd Dept. of Internal Medicine, School of Medicine, Comenius University, Bratislava, Slovakia, head prof. Andrej Dukát, M.D., Ph.D.
2 Research Laboratories, "John Paul II" Center for High Technology Research and Education in Biomedical Sciences, Catholic University of the Sacred Heart, Campobasso, Italy, head prof. Giovanni de Gaetano, M.D., Ph.D.
3 Dept. of Clinical Biochemistry, Military Hospital, Bratislava, Slovakia, head Pavol Blažíček, M.Sc.
4 Prevention and Rehabilitation Centre, University of Ottawa Heart Institute, Ottawa, Canada, head prof. George Fodor, M.D., Ph.D.

Background:
Due to limitations of the Friedewald formula, alternative methods for calculating low-density lipoprotein cholesterol (LDL-C) were suggested. We evaluated utility of these methods.

Methods: Ninety three subjects free of coronary heart disease were considered. LDL-C was measured by the homogeneous method, and calculated by the Friedewald formula LDL-C = TC - HDL - (TG/2.2) (LDL1) and alternative formulas LDL-C = 0.41 TC - 0.32 TG + 1.70 apoB - 0.27 (LDL2) and LDL-C = 0.94 TC - 0.94 HDL - 0.435 TG (LDL3).

Results:
All three formulas underestimated the measured LDL-C, both in the whole group and in subgroups according to TG levels (TG < 1.7 and in a range of 1.7-4.5 mmol/l, p < 0.001 for all). We found significantly higher bias for all three formulas in subjects with 1.7 ≤ TG < 4.5 mmol/l levels. The Friedewald formula showed the lowest assay bias in all the groups investigated. The mean absolute bias for LDL1 was 7.6 %, 18.3 % for LDL2 and 13.6 % for LDL3, respectively. Linear regression analysis showed correlation of calculated LDL-C values with the direct method in the range of r = 0.82 - 0.90 (p < 0.0001 for all, except of LDL2 in 1.7 ≤ TG < 4.5 mmol/l group where p = 0.0011).

Conclusions:
The Friedewald formula seems to be a better estimator of LDL-C in our study than the other two alternative formulas; however, it underestimated the LDL-C levels.

Keywords: LDL-C; alternative calculation formula; Friedewald formula

Received: May 15, 2008; Accepted: June 19, 2008; Published: October 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vohnout B, Vachulová A, Blažíček P, Dukát A, Fodor G, Lietava J. Evaluation of alternative calculation methods for determining LDL cholesterol. Vnitr Lek. 2008;54(10):961-964.
Download citation

References

  1. Nauck M, Rifai N. Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg2+ method. Clin Chim Acta 2000; 294: 77-92. Go to original source... Go to PubMed...
  2. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma without the use of preparative ultra centrifugation. Clin Chem 1972; 18: 499-509. Go to original source...
  3. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem 2002; 48: 236-254. Go to original source...
  4. Planella T, Cortes M, Martinez-Bru C et al. Calculation of LDL-cholesterol by using apolipoprotein B for classification of nonchylomicronemic dyslipemia. Clin Chem 1997; 43: 808-815. Go to original source...
  5. Hattori Y, Suzuki M, Tsushima M et al. Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL. Atherosclerosis 1998; 138: 289-299. Go to original source... Go to PubMed...
  6. Sniderman AD, Furberg CD, Keech A et al. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet 2003; 361: 777-780. Go to original source... Go to PubMed...
  7. Bairaktari E, Elisaf M, Tzallas Ch et al. Evaluation of five methods for determining low-density lipoprotein cholesterol (LDL-C) in hemodialysis patients. Clin Biochem 2001; 34: 593-602. Go to original source... Go to PubMed...
  8. Bairaktari ET, Tzallas C, Kalientzidou M et al. Evaluation of alternative calculation methods for determining low-density lipoprotein cholesterol in hemodialysis patients. Clin Biochem 2004; 37: 937-940. Go to original source... Go to PubMed...
  9. Bairaktari E, Hatzidimou K, Tzallas C et al. Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin Biochem 2000; 33: 549-555. Go to original source... Go to PubMed...
  10. Tremblay AJ, Morrissette H, Gagne JM et al. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004; 7: 785-790. Go to original source... Go to PubMed...
  11. Vachulová A, Vohnout B, Blažíček P et al. Vzťah kalkulovaného LDL cholesterolu k hladinám apolipoproteínu B u subjektov s normálnymi a zvýšenými hladinami triacylglycerolov. Cardiol 2005; 14: 88-91.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.